Inpharma Weekly

, Volume 1324, Issue 1, pp 9–9 | Cite as

Ranpirnase improves survival in malignant mesothelioma

Clinical study
  • 4 Downloads

Keywords

Partial Response Progressive Disease Survival Outcome Median Survival Time Eastern Cooperative Oncology Group 

Copyright information

© Adis International Ltd 2002

Personalised recommendations